Trial
NCT02110069
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Boston Children's Hospital
Collaborators
Pfizer
Condition
Kaposiform Hemangioendothelioma (KHE)
Intervention
Vincristine
Why stopped
This study was challenged by the incidence of KHE with KMP as this continued to be extremely rare, and very sporadic. In July of 2019 grant renewal funding ended.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-21